HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hypertriglyceridemia: lipoprotein receptors and atherosclerosis.

Abstract
We have shown first, that apoB mediates the binding of small VLDL Sf 20-60 and IDL, as well as LDL, to the LDL receptor. Second, apoE of an appropriate, accessible conformation is required for the binding of large VLDL to the LDL receptor; HTG-VLDL Sf greater than 60 but not normal VLDL Sf greater than 60 have this apoE population. Third, the same population of apoE that mediates binding of HTG-VLDL Sf greater than 60 to the LDL receptor modulates its binding to the beta-VLDL receptor, but it is not required for the latter interaction. Fourth, a domain of processed apoB or apoB-48 in association with a domain of the inaccessible apoE is required for binding to and uptake by the beta-VLDL receptor. Fifth, our observations suggest that the abnormal catabolism of VLDL that occurs in hypertriglyceridemia may be explained by the abnormal uptake of HTG-VLDL by either the LDL or the beta-VLDL receptor pathway. Finally, we suggest that plasma proteases may route apoB/E-containing lipoproteins to macrophages for disposal, and this results in foam cell formation.
AuthorsS H Gianturco, A M Gotto Jr, W A Bradley
JournalAdvances in experimental medicine and biology (Adv Exp Med Biol) Vol. 183 Pg. 47-71 ( 1985) ISSN: 0065-2598 [Print] United States
PMID4036704 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Apolipoproteins B
  • Apolipoproteins E
  • Lipoproteins
  • Lipoproteins, IDL
  • Lipoproteins, LDL
  • Lipoproteins, VLDL
  • Receptors, LDL
  • Triglycerides
  • VLDL receptor
  • Thrombin
Topics
  • Apolipoproteins B (metabolism)
  • Apolipoproteins E (metabolism)
  • Arteriosclerosis (metabolism)
  • Cells, Cultured
  • Fibroblasts (metabolism)
  • Humans
  • Hyperlipoproteinemia Type IV (metabolism)
  • Lipoproteins (metabolism)
  • Lipoproteins, IDL
  • Lipoproteins, LDL (metabolism)
  • Lipoproteins, VLDL (metabolism)
  • Macrophages (metabolism)
  • Receptors, LDL (metabolism)
  • Structure-Activity Relationship
  • Thrombin (metabolism)
  • Triglycerides (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: